Home » Stocks » Psychemedics

Psychemedics Corporation (PMD)

Stock Price: $4.89 USD 0.16 (3.38%)
Updated Aug 4, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 27.02M
Revenue (ttm) 35.39M
Net Income (ttm) 756,000
Shares Out 5.53M
EPS (ttm) 0.14
PE Ratio 34.93
Forward PE n/a
Dividend $0.72
Dividend Yield 14.72%

Stock Quote

Trading Day Aug 4, 2020
Last Price $4.89
Previous Close $4.73
Change ($) 0.16
Change (%) 3.38%
Day's Open 4.70
Day's Range 4.61 - 4.90
Day's Volume 35,449
52-Week Range 4.51 - 10.69

More Stats

Market Cap 27.02M
Enterprise Value 27.25M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 5.53M
Float 4.65M
EPS (basic) 0.13
EPS (diluted) 0.14
FCF / Share 0.29
Dividend $0.72
Dividend Yield 14.72%
Earnings Yield 2.86%
FCF Yield 5.91%
Payout Ratio 553.80%
Shares Short 21,510
Short Ratio 0.63
Short % of Float 0.30%
Beta 0.88
PE Ratio 34.93
Forward PE n/a
P/FCF Ratio 16.92
PS Ratio 0.76
PB Ratio 1.72
Revenue 35.39M
Operating Income 1.81M
Net Income 756,000
Free Cash Flow 1.60M
Net Cash -229,000
Net Cash / Share -0.04
Gross Margin 46.46%
Operating Margin 5.12%
Profit Margin 2.10%
FCF Margin 4.51%
ROA 6.44%
ROE 4.41%
ROIC 9.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $4.89
Target: 32.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-11.71%7.49%1.85%44.5%-7.64%8.69%6.53%4.71%19.8%-
Gross Profit16.4420.6219.8221.4512.7215.1415.3914.2514.4712.04
Operating Income3.007.618.1610.111.474.635.714.945.804.41
Net Income1.544.586.126.681.513.213.812.983.492.61
Shares Outstanding5.515.505.485.455.415.365.305.265.235.21
Earnings Per Share0.280.831.
EPS Growth-66.27%-24.55%-9.84%335.71%-53.33%-16.67%26.32%-14.93%34%-
Dividend Per Share0.720.690.600.600.600.600.600.600.480.48
Dividend Growth4.35%15%0%0%0%0%0%25%0%-
Operating Cash Flow4.317.939.159.274.584.465.953.093.943.30
Capital Expenditures-1.73-1.32-1.25-2.09-1.80-7.81-1.76-2.34-1.49-0.82
Free Cash Flow2.586.617.907.182.78-3.354.190.752.452.48
Cash & Equivalents7.287.978.173.942.693.613.973.075.565.74
Total Debt5.971.633.383.385.896.25----
Net Cash / Debt1.326.354.790.56-3.20-2.643.973.075.565.74
Book Value16.8218.7518.6215.6111.6712.8412.2811.2211.039.75
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Psychemedics Corporation
Country United States
Employees 204
CEO Raymond C. Kubacki

Stock Information

Ticker Symbol PMD
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: PMD


Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts.